282 related articles for article (PubMed ID: 31850704)
1. A Novel Long Non-Coding RNA KMU15 Promotes Growth and Chemoresistance of Bladder Cancer.
Huang Y; Luan T; Bao X; Fu S; Li N; Li H; Wang H; Li C; Wang J
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850704
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
3. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
4. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
5. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
6. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
7. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
8. High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer.
Qin Z; Wang Y; Tang J; Zhang L; Li R; Xue J; Han P; Wang W; Qin C; Xing Q; Yang J; Zhang W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054424
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA
Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.
Zhao F; Lin T; He W; Han J; Zhu D; Hu K; Li W; Zheng Z; Huang J; Xie W
Oncotarget; 2015 Jan; 6(2):1064-78. PubMed ID: 25473900
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361.
Wu X; Zheng Y; Han B; Dong X
Biomed Pharmacother; 2018 Mar; 99():832-838. PubMed ID: 29710482
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
[TBL] [Abstract][Full Text] [Related]
14. Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
Dai R; Zhou Y; Chen Z; Zou Z; Pan Z; Liu P; Gao X
J Cell Biochem; 2020 Oct; 121(10):4214-4225. PubMed ID: 31898364
[TBL] [Abstract][Full Text] [Related]
15. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
16. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
Woolbright BL; Choudhary D; Mikhalyuk A; Trammel C; Shanmugam S; Abbott E; Pilbeam CC; Taylor JA
Mol Cancer Ther; 2018 Sep; 17(9):2004-2012. PubMed ID: 29907593
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
Li J; Li Y; Meng F; Fu L; Kong C
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]